Vasculitis

Good Flow: 2021 Updates in Vasculitis

December 6, 2021 • By Jason Liebowitz, MD

What Rheumatologists Should Know About Childhood-Onset SLE & Vasculitis

December 2, 2021 • By Mary Beth Nierengarten

10 Clinical Insights & Rheumatology Pearls Presented at ACR Convergence 2021

December 2, 2021 • By Mithu Maheswaranathan, MD

Clinical Rheumatology Year in Review

November 22, 2021 • By Samantha C. Shapiro, MD

Case Report: A Rare Mimic of Giant Cell Arteritis

November 14, 2021 • By Iryna Nemesh, MD, Saleema Kherani, MD MPH, Shikha Singla, MD, & William Wirostko, MD

Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

November 14, 2021 • By Ashraf Raslan, MD, Dorian Infantino, MD, Roman Zuckerman, DO, & Daniel Berlin, MD

Considerations for Prescribing Avacopan for ANCA-Associated Vasculitis

October 27, 2021 • By Michele B. Kaufman, PharmD, BCGP

How Do Reduced-Dose Glucocorticoids Plus Rituximab Affect ANCA-Associated Vasculitis?

October 13, 2021 • By Lara C. Pullen, PhD

Vasculitis Guidelines in Focus, Part 5: Takayasu Arteritis

October 11, 2021 • By Michael Putman, MD

FDA Approves Avacopan for the Treatment of ANCA-Associated Vasculitis

October 8, 2021 • By ChemoCentryx

1
2
3
…
16
Next Page »